Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq analysis of transcriptomes of thymus derived tTreg cells and the exFoxp3 precursor cells

ABSTRACT: To determine the phenotype of the precursor of exFoxp3 cells and find the signals that affect the stability of tTreg cells, we analysis the transcriptomes of epigenetic stable thymus derived tTreg cells and the exFoxp3 precursor cells.

ORGANISM(S): Mus musculus

PROVIDER: GSE93856 | GEO | 2017/03/01

SECONDARY ACCESSION(S): PRJNA362608

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Proteomics reveals unique identities of human TGF-β-induced and thymus-derived CD4+ regulatory T cells

Project description:The CD4+ regulatory T (Treg) cell lineage comprises thymus-derived (t)Treg cells and peripherally induced (p)Treg cells. As a model for Treg cells, studies employ TGF-β-induced (i)Treg cells generated from CD4+ conventional T (Tconv) cells in vitro. Here, we describe the relationship of iTreg cells to tTreg and Tconv cells. Proteomic analysis revealed that iTreg, tTreg and Tconv cell populations each have a unique protein expression pattern. iTreg cells had very limited overlap in protein expression with tTreg cells, regardless of cell activation status and instead shared signaling and metabolic proteins with Tconv cells. tTreg cells had a uniquely modest response to CD3/CD28-mediated stimulation. As a benchmark, we used a previously defined proteomic signature that sets ex vivo naïve and effector phenotype Treg cells apart from Tconv cells and includes unique Treg cell properties (Cuadrado et al., Immunity, 2018). This Treg cell core signature was largely absent in iTreg cells. We also used a proteomic signature that distinguishes ex vivo effector Treg cells from Tconv cells and naïve Treg cells. This effector Treg cell signature was partially present in iTreg cells. In conclusion, iTreg cells are distinct from tTreg cells and share limited features with ex vivo Treg cells at the proteomic level.

2022-11-28 | PXD038302 | Pride

Comparison of human CD39- and CD39+ thymus-derived regulatory T-cells

Project description:CD39- and CD39+ human thymus-derived regulatory T-cells (tTreg) present as distinct subsets with specific functional and metabolic response patterns. Both cell types express equal levels of the canonical tTreg transcription factors FOXP3 and Helios and overexpression studies have shown that CD39 expression is independent of these two transcription factors. So far, no transcriptomic analyses to adress these differences have been performed. We used microarrays to detail the global programme of gene expression between CD39- and CD39+ human tTreg and identified distinct classes of up-regulated and down-regulated genes between these two subsets.

2020-07-02 | GSE131743 | GEO

Mus musculus

Project description:RNA-seq analysis of transcriptomes of thymus derived tTreg cells and the exFoxp3 precursor cells

| PRJNA362608 | ENA

iPS derived melanocyte precursor cells

Project description:iPS derived melanocyte precursor cells

| PRJNA484898 | ENA

Transcriptomes of antigen presenting cells in human thymus.

Project description: Not available

| S-EPMC6602790 | biostudies-literature

Treg cells from human blood differentiate into non-lymphoid tissue-resident effector cells upon TNFR2 costimulation

Project description:Regulatory T (Treg) cells can facilitate transplant tolerance and attenuate autoimmune- and inflammatory diseases. Therefore, it is clinically relevant to stimulate Treg cell expansion and function in vivo and to create therapeutic Treg cell products in vitro. We report that TNF receptor 2 (TNFR2) is a unique costimulus for naïve, thymus-derived (t)Treg cells from human blood that promotes their differentiation into non-lymphoid tissue (NLT)-resident effector Treg cells, without Th-like polarization. In contrast, CD28 costimulation maintains a lymphoid tissue (LT)-resident Treg cell phenotype. We base this conclusion on transcriptome and proteome analysis of TNFR2- and CD28-costimulated CD4+ tTreg cells and conventional T (Tconv) cells, followed by bioinformatic comparison with published transcriptomic Treg cell signatures from NLT and LT in health and disease, including autoimmunity and cancer. These analyses illuminated that TNFR2 costimulation promotes tTreg cell capacity for survival, migration, immunosuppression and tissue regeneration. Functional studies confirmed improved migratory ability of TNFR2-costimulated tTreg cells. Flow cytometry validated the presence of the TNFR2-driven tTreg cell signature in effector/memory Treg cells from the human placenta as opposed to blood. Thus, TNFR2 can be exploited as driver of NLT-resident tTreg cell differentiation for adoptive cell therapy or antibody-based immunomodulation in human disease.

2024-01-23 | GSE253540 | GEO

Thymus vulgaris

Project description:Thymus vulgaris overview

| PRJNA625142 | ENA

Epigenetic profiling reveals developmental traits of adult thymus-derived Vγ4+ γδ T cells

Project description:Recent advances in next-generation sequencing technologies elucidated gene regulatory networks and TCR signaling molecules underlying functional differentiation into γδ1 and γδ17 cells that now provide valid resources to define developing CD24+ γδ, γδ1 and γδ17 cells. The γδ1 cell subsets express key transcription factors of cytotoxicity and IFNγ-production, such as Tbx21 (encoding T-bet) and Eomes, as well as natural killer receptor (NKRs). Development of γδ17 cells is favorable in the early life period, regulated by Notch signaling and a network of transcriptional regulators including cMaf, Sox13, Blk, and Rorc that are essential for functional differentiation. However, detailed knowledge about molecular programs of Vγ4 cells, including their potential to become γδ1 or γδ17 cells during adult thymus development, is lacking. Here we employed transcriptional and epigenetic analysis of Vγ4 cells under steady-state conditions and after induction of de novo T cell development from adult thymus precursor cells.

2023-01-13 | GSE222588 | GEO

Gene expression profile of regulatory T cell (Treg) subsets from CD28-deficient mouse

Project description:A comparative analysis of gene expression of CD4+ EGFP+ Nrp1+ (tTreg, thymus-derived Treg), CD4+ EGFP+ Nrp1- (pTreg, peripherally-derived Treg) and CD4+ EGFP- (Tconv, conventional T cell) in CD28-/- Foxp3EGFP and Foxp3EGFP mice.

2017-06-29 | GSE92376 | GEO

Alpha/Beta Mouse TCR Sequencing of CD4+ thymic regulatory and conventional T-cells

Project description:Thymic regulatory T cells (tTreg) are critical in maintenance of normal T cell immunity and tolerance. The role of TCR in tTreg cell selection remains incompletely understood. Here we assessed TCRa and TCRb sequences of tTreg and conventional thymic CD4+ T (Tconv) cells by high throughput sequencing. We identified ab TCR sequences that were unique to either tTreg or Tconv cells and found that these were distinct as recognized by machine learning (ML) algorithm and by preferentially used amino acid trimers in ab CDR3 of tTreg cells. In addition, a proportion of ab TCR sequences expressed by tTreg were also found in Tconv cells, and ML classified the great majority of these shared ab TCR sequences as characteristic of Tconv and not tTreg cells. These findings identify two populations of tTreg, one in which Treg fate is associated with unique properties of the TCR, and another with TCR properties characteristic of Tconv cells for which tTreg fate is determined by factors beyond TCR sequence.

2020-01-10 | GSE143291 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data